Thrombin peptide, TP508, stimulates angiogenic responses in animal models of dermal wound healing, in chick chorioallantoic membranes, and in cultured human aortic and microvascular endothelial cells
- 1 November 2000
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 35 (5) , 249-254
- https://doi.org/10.1016/s0306-3623(01)00118-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Inflammation–coagulation network: are serine protease receptors the knot?Trends in Pharmacological Sciences, 2000
- Antiangiogenic tumour therapy: will it work?Trends in Pharmacological Sciences, 1998
- Presented at the 1995 Microcirculatory Society MeetingMicrocirculation, 1996
- Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides.Journal of Clinical Investigation, 1992
- Role of High-Affinity Thrombin Receptors in Postclotting Cellular Effects of ThrombinSeminars in Thrombosis and Hemostasis, 1992
- Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane.The Journal of cell biology, 1990
- Induction of angiogenesis by mixtures of two angiogenic proteins, angiogenin and acidic fibroblast growth factor, in the chick chorioallantoic membraneBiochemical and Biophysical Research Communications, 1987
- Double-Signal Hypothesis for Thrombin Initiation of Cell ProliferationSeminars in Thrombosis and Hemostasis, 1986
- Growth‐promoting effects of esterolytically inactive thrombin on macrophagesJournal of Cellular Biochemistry, 1986
- Initiation of proliferative events by human ?-thrombin requires both receptor binding and enzymic activityJournal of Cellular Biochemistry, 1984